Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 536.00
Bid: 538.00
Ask: 541.00
Change: -11.00 (-2.01%)
Spread: 3.00 (0.558%)
Open: 544.00
High: 544.00
Low: 535.00
Prev. Close: 547.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AUM Update

14 Jan 2011 07:00

RNS Number : 4390Z
Polar Capital Holdings PLC
14 January 2011
 



14 January 2011

 

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Comment

 

We are pleased to report an increase of 40% in our AUM to over $3.5bn in the nine month period to December 2010. The Group remains confident that its strategy of growing its established funds to capacity and expanding its product range through both hiring and acquiring new teams will continue to drive future AUM growth.

 

We are also pleased to confirm an increase in net performance fee receipts over the period. Such fees total £5.6m (2009: £2.3m) as a result of the continued good performance of a number of the Group's products.

 

Group AUM (unaudited)

 

The table below sets out the Group's AUM as at 31 December 2010 and the movements experienced in the nine month period since 31 March 2010:

 

AUM movement

Nine months to 31 Dec 10

Long only funds

$m

Hedge funds

$m

Total

$m

As at 31 Mar 2010

$1,575m

$955m

$2,530m

Performance and currency movements

$259m

$18m

$277m

Acquisition of HIM Capital

$249m

-

$249m

Net subscriptions / (redemptions) from ongoing businesses

$572m

$(122)m

$450m

Total AUM at 31 Dec 10

$2,655m

$851m

$3,506m

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fees (after the deduction of staff interests) earned and accrued in the first nine months of the Group's financial year.

 

Performance fees

net of staff allocations

Nine months to

31 Dec 09

£m

Year to

31 Mar 10

(year end)

£m

Nine months to

31 Dec 10

£m

Received

£1.9m

£2.5m

£5.6m

Accrued but not yet earned in funds with year ends on or before the financial year end

£0.4m

n/a

£0.0m

Total net performance fees

£2.3m

£2.5m

£5.6m

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (CFO)

+44 (0)20 7227 2700

 

Numis Securities

Simon Blank (Nominated Adviser)

Charles Farquhar (Corporate Broking)

 

 

+44 (0)20 7260 1000

 

Financial Dynamics

Ed Gascoigne-Pees

Georgina Turner

 

 

+44 (0)20 7269 7132

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALFDFLPFEFF
Date   Source Headline
10th Jan 201910:19 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSAUM Update
2nd Jan 20199:49 amRNSTotal Voting Rights
12th Dec 20184:00 pmRNSIssue of Equity
27th Nov 20184:40 pmRNSSecond Price Monitoring Extn
27th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018
11th Jun 201811:27 amRNSNet Asset Value(s)
1st Jun 20187:41 amRNSTotal Voting Rights
24th May 201810:59 amRNSDirector/PDMR Shareholding
24th May 20189:35 amRNSIssue of Equity
23rd May 201811:00 amRNSNotice of Results
23rd May 20189:37 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.